News and Announcements
ESIC-Approved Secure2Go Signs MOU with Leading Global Insurer MunichRE
- Published June 26, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Investment Update
- MOU executed with leading global insurer, MunichRE:
- includes pilot programs for SECUREboat in the UK and US focusing on improving the customers experience, the claim validation process and enhancing technical pricing;
- clear path to a long term contractual agreement;
- option for an equity investment to secure exclusivity in the global insurance sector;
- Opportunity to access additional market segments.
- OEM arrangements with UK and US boat builders:
- Five high end luxury boat builders installing and testing SECUREboat;
- Target for the product becoming a standard install acrossexisting customer database. the annual 10,000+ new boats built with retro-fit rollout across the 100,000+
- Automotive dealership rollout commenced:
- Completed first SECUREdrive retail unit sales;
- SECUREfleet installation underway with dealerships in Western Australia.
Secure2Go Investors, are eligible for the ESIC tax incentive before June 30th 2017.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
